ten23 health AG, headquartered in Switzerland (CH), is a pioneering company in the biopharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2020, ten23 health has quickly established itself as a leader in the field, focusing on the creation of unique formulations that enhance the efficacy and safety of therapeutic agents.
With a strong operational presence across Europe, ten23 health AG offers a range of core services, including formulation development, analytical services, and regulatory support. Their commitment to advancing drug delivery technologies sets them apart, enabling clients to navigate complex challenges in the pharmaceutical landscape. Recognised for their expertise and innovative solutions, ten23 health continues to make significant strides in improving patient outcomes and solidifying their market position.
+18 vs industry average
ten23 health AG’s score of 47 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at ten23 health AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Chemicals is among the most carbon-intensive industries
Industry performance
The Chemicals industry has reduced its overall emissions by 6% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
ten23 health AG's reported carbon emissions
In 2024, ten23 health AG reported total carbon emissions of approximately 13,045,500 kg CO2e, comprising 700 kg CO2e from Scope 1, 86,300 kg CO2e from Scope 2 (market-based), and 13,045,500 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce its overall emissions by 90% by 2050 from a 2023 baseline. This includes specific targets of a 42% reduction in Scope 1 and Scope 2 emissions by 2030. In 2023, the total emissions were approximately 15,423,300 kg CO2e, with Scope 1 emissions at 500 kg CO2e, Scope 2 emissions (market-based) at 112,700 kg CO2e, and Scope 3 emissions at 15,423,300 kg CO2e. The previous year, 2022, saw total emissions of approximately 5,771,800 kg CO2e, with Scope 1 at 400 kg CO2e, Scope 2 (market-based) at 131,300 kg CO2e, and Scope 3 at 5,771,800 kg CO2e. Ten23 health AG is committed to achieving net-zero emissions by 2050, with a focus on measuring and reducing its Scope 3 emissions as part of its sustainability strategy. The company’s targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
ten23 health AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for ten23 health AG yet.
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about ten23 health AG’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project